FBIO
FBIO
NASDAQ · Biotechnology

Fortress Biotech Inc

$2.76
-0.12 (-4.17%)
As of Mar 29, 10:42 PM ET ·
Financial Highlights (FY 2026)
Revenue
79.77M
Net Income
-63,618,983
Gross Margin
63.8%
Profit Margin
-79.8%
Rev Growth
-5.7%
D/E Ratio
2.58
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 63.8% 63.8% 45.7% 45.7%
Operating Margin -191.4% -172.2% -4.5% -4.2%
Profit Margin -79.8% -75.8% -3.3% -4.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 79.77M 84.60M 15.02M 12.01M
Gross Profit 50.89M 53.97M 6.86M 5.49M
Operating Income -152,661,516 -145,715,732 -676,721 -503,400
Net Income -63,618,983 -60,724,450 -500,427 -503,355
Gross Margin 63.8% 63.8% 45.7% 45.7%
Operating Margin -191.4% -172.2% -4.5% -4.2%
Profit Margin -79.8% -75.8% -3.3% -4.2%
Rev Growth -5.7% -5.7% +23.3% -6.8%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 30.86M 30.86M 48.01M 47.34M
Total Equity 11.98M 11.98M 62.00M 58.63M
D/E Ratio 2.58 2.58 0.77 0.81
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -146,104,325 -147,204,484 -867,054 -674,727
Free Cash Flow -309,659 -330,972